Common Contracts
4 similar Underwriting Agreement contracts by Vanda Pharmaceuticals Inc., Flagstar Bancorp Inc, Volcano CORP
FLAGSTAR BANCORP, INC. 110,000,000 Shares of Common Stock ($0.01 par value per share) 13,500,000 Shares of Mandatorily Convertible Non-Cumulative Perpetual Preferred Stock Series D ($0.01 par value per share) UNDERWRITING AGREEMENTUnderwriting Agreement • November 2nd, 2010 • Flagstar Bancorp Inc • Savings institution, federally chartered • New York
The illustrative ratios below assume the completion, as of September 30, 2010, of (i) the offering of Common Stock (assuming no exercise of the underwriter’s over-allotment option), after deducting underwriter’s discounts and commissions and estimated offering expenses, (ii) the offering of Convertible Preferred Stock (assuming no exercise of the underwriter’s over-allotment option), after deducting underwriter’s discounts and commissions and estimated
Volcano Corporation 7,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • October 18th, 2007 • Volcano CORP • Electromedical & electrotherapeutic apparatus • New York
Volcano Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 7,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,050,000 shares of common stock, par value $0.001 per share, of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock, par value $0.001 per share of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”. The Stock, including the Shares, have or will have attached thereto rights (the “Rights”) to purchase Series A Junior Participating Preferred Stock. The Rights were issued or are to be issued, as applicable, pursuant to a Righ
VANDA PHARMACEUTICALS INC. 3,500,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • January 17th, 2007 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Vanda Pharmaceuticals Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,500,000 shares of Common Stock, par value $0.001 per share, of the Company (the “Underwritten Shares” and, at the option of the Underwriters, up to an additional 525,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”). The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.
VANDA PHARMACEUTICALS INC. 3,500,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • January 9th, 2007 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Vanda Pharmaceuticals Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,500,000 shares of Common Stock, par value $0.001 per share, of the Company (the “Underwritten Shares” and, at the option of the Underwriters, up to an additional 525,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”). The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.
